Medical Marijuana, Inc. Subsidiary Kannaway Launches in

SAN DIEGO, CA, September 01, 2021 (GLOBE NEWSWIRE) – via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first publicly traded cannabis company in the United States to become the world’s first to make cannabis established nutraceutical products, brands and supply chains, announced today that the Kannaway® subsidiary has started operations in Hong Kong.

“Our first expansion in Asia was a fantastic success in Japan and we are now looking forward to bringing our high quality cannabidiol (CBD) products to Hong Kong,” said Kannaway® CEO Blake Schroeder. “Hemp has a long history in the region and, according to MJBizDaily, China is the world’s largest producer of hemp. Now, as the global popularity of CBD grows, we see Hong Kong citizens wanting back” their roots are using hemp-derived CBD. “

Kannaway® will host regional events to educate current and potential brand ambassadors about the many potential wellness benefits and financial opportunities of hemp CBD oil.

About Kannaway®
Kannaway® is a network sales and marketing company specializing in the sale and marketing of hemp-based herbal products. Kannaway® currently hosts weekly online sales meetings and conferences in the United States, providing unique insights and opportunities to sales professionals who want to become successful leaders in the sales and marketing of hemp-based herbal products.

About Medical Marihuana, Inc.

We are a firsts® company. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct businesses in the non-psychoactive cannabinoids space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest quality legal non-psychoactive cannabis products made from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners such as AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. has been recognized as a premier CBD producer by CNBC. Medical Marijuana, Inc. was also the first to obtain historic import permits for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a leader in developing international markets. The company’s flagship product, Real Scientific Hemp Oil, has been used in several successful clinical trials across Mexico and Brazil to understand its safety and effectiveness.

Medical Marijuana, Inc. is headquartered in San Diego, California. Additional information is available at OTCMarkets.com or www.medicalmarijuanainc.com. Click here to watch Medical Marijuana, Inc. corporate video.

FORWARD LIABILITY DISCLAIMER

This press release may contain certain forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor established by those sections. This material contains statements about expected future events and / or financial results that are forward-looking and involve risks and uncertainties. Such forward-looking statements, by definition, involve risks, uncertainties and other factors that could cause the actual results, performance or accomplishments of Medical Marijuana, Inc. to differ materially from the statements made herein.

FOOD AND DRUG ADMINISTRATION DISCLOSURE (FDA)

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute products that violate United States Controlled Substances Act.

CONTACT:

Contact person for public relations:
Kathryn Brown
Account Director
CMW media
Pp. 858-264-6600
kathryn@cmwmedia.com
www.cmwmedia.com

Investor Relations Contact:
Pp. (858) 283-4016
Investors@medicalmarijuanainc.com